You have 9 free searches left this month | to do more

Adavosertib

Adavosertib is a drug used to treat Advanced Malignant Solid Neoplasm, Recurrent Ovarian Carcinoma, Cervical Carcinoma, and other conditions. Adavosertib is being actively studied in 18 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)Dana-Farber Cancer InstituteJames Cleary, MD, PhD
AstraZenecaM D Anderson Cancer Center
M.D. Anderson Cancer CenterUniversity of Pittsburgh Cancer Institute (UPCI)
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Not yet recruiting
  • Pancreatic Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2022-01-23
Jan 23, 2022
A
Active, not recruiting
  • Advanced Solid Tumours
  • Adavosertib
  • Newnan, Georgia
  • +14 more
2022-03-15
Mar 15, 2022
M
Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Adavosertib
  • +2 more
  • Boston, Massachusetts
  • +1 more
2022-03-09
Mar 9, 2022
A
Recruiting
  • Advanced Solid Tumours
  • Adavosertib
  • +3 more
  • New Haven, Connecticut
  • +11 more
2022-03-22
Mar 22, 2022
A
Active, not recruiting
  • Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
  • Adavosertib
  • +4 more
  • Gilbert, Arizona
  • +19 more
2022-02-23
Feb 23, 2022
A
Active, not recruiting
  • Uterine Serous Carcinoma
  • Adavosertib
  • Birmingham, Alabama
  • +41 more
2021-11-30
Nov 30, 2021
M
Recruiting
  • Advanced Fallopian Tube Carcinoma
  • +21 more
  • Adavosertib
  • Laboratory Biomarker Analysis
  • Portland, Oregon
  • +7 more
2022-01-18
Jan 18, 2022
N
Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Adavosertib
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
2022-02-04
Feb 4, 2022
N
Active, not recruiting
  • Anaplastic Astrocytoma
  • +5 more
  • Adavosertib
  • +3 more
  • Birmingham, Alabama
  • +23 more
2022-01-28
Jan 28, 2022
N
Active, not recruiting
  • Central Nervous System Embryonal Tumor With Rhabdoid Features
  • +14 more
  • Adavosertib
  • Irinotecan Hydrochloride
  • Birmingham, Alabama
  • +23 more
2021-09-15
Sep 15, 2021
N
Active, not recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Adavosertib
  • +2 more
  • Birmingham, Alabama
  • +11 more
2022-03-15
Mar 15, 2022
N
Suspended
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Adavosertib
  • Duarte, California
  • +8 more
2022-03-15
Mar 15, 2022
C
Recruiting
  • Prostate Cancer
  • Adavosertib
  • +6 more
  • Edmonton, Alberta, Canada
  • +11 more
2022-02-14
Feb 14, 2022
N
Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • Adavosertib
  • +5 more
  • Aurora, Colorado
  • +7 more
2021-05-06
May 6, 2021
N
Suspended
  • Clinical Stage III Esophageal Adenocarcinoma AJCC v8
  • +58 more
  • Adavosertib
  • Radiation Therapy
  • Duarte, California
  • +6 more
2022-02-24
Feb 24, 2022
N
Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +6 more
  • Adavosertib
  • Orange, California
  • +28 more
2022-03-01
Mar 1, 2022
N
Active, not recruiting
  • Cervical Carcinoma
  • +23 more
  • Adavosertib
  • +2 more
  • Sacramento, California
  • +7 more
2021-11-09
Nov 9, 2021
N
Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Adavosertib
  • +5 more
  • Duarte, California
  • +14 more
2022-02-05
Feb 5, 2022
N
Terminated
  • Acute Myeloid Leukemia
  • +10 more
  • Adavosertib
  • +3 more
  • Tampa, Florida
  • +1 more
2018-05-24
May 24, 2018
N
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Adavosertib
  • +33 more
  • Birmingham, Alabama
  • +1423 more
2022-04-06
Apr 6, 2022